Tan Sri Dato'
Dr Abu Bakar bin Suleiman
Before IHH Healthcare Berhad (IHH or the Group) was publicly listed in 2012, not many people were aware of the name. We had well-known brands such as Gleneagles, Mount Elizabeth, Pantai, ParkwayHealth and Acibadem within our portfolio, but the Group itself was under the radar. Today, IHH has gained much more than name recognition, it has also won the trust of our key stakeholders, namely our doctors, patients, employees, partners and shareholders.
We have delivered on our IPO promise - to turn IHH into a global brand - strengthening our operations in our home markets of Malaysia, Singapore and Turkey; and expanding into key markets in Asia and Central and Eastern Europe, Middle East and North Africa (CEEMENA). The speed with which we have executed our growth plans so far has been truly amazing. In just four years, we have grown from having over 4,900 licensed beds in 33 hospitals to becoming the largest private hospital group in the Pan-Asian region with close to 10,000 licensed beds in 49 hospitals. The 10,000-bed milestone was a target we had set for ourselves for 2017. That we have achieved that goal two years in advance speaks volumes of the Group's strategic management and commitment.
Click here to view our Chairman's Statement